TBTimothy Andrew Becker

Timothy Andrew Becker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Timothy Andrew Becker has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Flow Redistribution in Circle of Willis Branches After Flow Diversion: Impetus for Vascular Remodeling?

    by Sophia E. Robertson, Felipe Ramirez-Velandia, Emmanuel O. Mensah, Jesse C. Wells, Wyatt E. Clark, Steven A. Schwartz, Kailey L. Lewis, Holly F. Berns, Kana'I Hakes, Christopher Rapoport, et al.

    BACKGROUND AND OBJECTIVES: Flow diverters (FDs) can induce vascular remodeling in nontarget branches of the circle of Willis (CW), yet the hemodynamic drivers of these changes remain unclear. Using in vitro CW models, flow rate alterations were quantified across both target and contralateral CW branches after FD deployment. METHODS: Four 3-dimensional–printed CW models were created (standard and hypoplastic variants) and integrated into a physiological pulsatile flow loop. Flow rates and pressures were recorded in all major branches before and after sequential deployment of 3 concentric FDs. Eight experiments were performed across the 4 models to capture anatomy-dependent hemodynamic responses. RESULTS: Across all 4 FD configurations, deployment produced significant flow redistribution both in the covered branch and in remote CW vessels. Covered vessels showed progressive flow reductions of up to 14% after 3 FDs, particularly in hypoplastic anatomies. Importantly, contralateral and collateral pathways also demonstrated measurable redistribution: contralateral anterior cerebral artery flow decreased by up to 4.7%, middle cerebral artery flow increased by 2% to 5%, and posterior cerebral artery flow shifted by 3% to 8% depending on the FD location. Several of these compensatory changes reached statistical significance despite occurring in branches not directly covered by the device, underscoring the CW's sensitivity to localized resistance changes. CONCLUSION: FD placement produced significant, anatomy-dependent changes in branch flow rate and pressures. Hypoplastic models exhibited more pronounced redistribution patterns than standard CW anatomy, highlighting the role of baseline vessel diameter. These findings support a mechanistic explanation for clinically reported post-treatment vascular remodeling.

  • A 3D ‐Printed Rupture‐Prone Aneurysm Model for Assessing the Safety and Efficacy of Endovascular Devices

    by Husain Sodawalla, Mohammed Alnajrani, Jesse Wells, Steven Schwartz, Callum Fisher, Kailey Lewis, Timothy A. Becker

    Currently available in vitro benchtop aneurysm models often lack material characteristics for testing the efficacy of endovascular devices. Specifically, current models do not represent the mechanical instability of giant aneurysms and do not predictably rupture under simulated physiological conditions. Hence, in vitro aneurysm models with biomechanically relevant material properties and a predictable rupture timeframe are needed to accurately assess the efficacy of new medical device treatment options. A 3D‐printed giant aneurysm model was developed that can predictably rupture in 2 h when left untreated under physiological conditions to test hemodynamic effects of endovascular treatments. Aneurysm treatment simulations included flow diverter‐only treatment, flow diverter with synthetic thrombus treatment, and flow diverter with liquid embolic treatment, ran in parallel with untreated controls. The flow diverter only treatment ruptured in 47 (±41) min as compared to 54 (±30) min for controls ( p value = 0.36). The flow diverter with synthetic thrombus treatment ruptured in 22 (±16) min as compared to 19 (±10) min for controls ( p value = 0.71). The flow diverter with liquid embolic treatment ruptured in 61 (±27) min as compared to 35 (±17) min for controls ( p value = 0.16). Utilizing physiological benchtop in vitro models, aneurysm rupture can be repeatedly predicted to test the efficacy of medical device treatments. Further studies will investigate the optimization of the engineered aneurysm dome defect with tunable rupture times based on the measurable pressure and flow effects. These optimized in vitro models could ultimately evaluate aneurysm rupture risk and location after treatment.

  • Application of 3D printing to create an in vitro aneurysm rupture model

    by Husain Sodawalla, Mana Alyami, Timothy A. Becker

    Currently available benchtop (in vitro) aneurysm models are inadequate for testing the efficacy of endovascular device treatments. Specifically, current models do not represent the mechanical instability of giant aneurysms (defined as aneurysms with 25 mm in height or width) and do not predictably rupture under simulated physiological conditions. Hence, in vitro aneurysm models with biomechanically relevant material properties and a predictable rupture timeframe are needed to accurately assess the efficacy of new medical device treatment options. Understanding the material properties of an aneurysm (e.g., shear and compression modulus) as it approaches rupture is a crucial step toward creating a pathologically relevant and sophisticated in vitro aneurysm rupture model. We investigated the change in material properties of a blood vessel, via enzymatic treatment, to simulate the degradation of an aneurysm wall and used this information to create a sophisticated aneurysm rupture model using the latest in additive manufacturing technologies (3D printing) with tissue‐like materials. Mechanical properties (shear and compression modulus) of swine carotid vessels were evaluated before and after incubation with collagenase D enzyme (30 min at 37°C) to simulate the effect of biochemical activity on aneurysm wall approaching rupture compared to control vessels (untreated). Mechanical strength of a soft and flexible 3D‐printed material (VCA‐A30: 30 shore A hardness) was tested for comparison to these arterial vessels. This material was then used to create spherical shaped, giant‐sized (25‐mm diameter) aneurysm phantoms and were run under neurovascular pressures (120/80 ± 5 mmHg), beats per minute (BPM = 70) and flows representing the middle cerebral artery [MCA: 142.67 (±20.13) mL/min] using a blood analog [3.6 (±0.4) cP viscosity] with non‐Newtonian shear‐thinning properties. The shear modulus of swine carotid vessel before treatment was 12.2 (±2.7) KPa and compression modulus was 663.5 (±111.6) KPa. After enzymatic treatment by collagenase D, shear modulus of animal tissues reduced by 33% ( p ‐value = .039) while compression modulus remained statistically unchanged ( p ‐value = .615). Control group (untreated vessels) showed minimal reduction (13%, p ‐value = .226) in shear modulus and 78% increase ( p ‐value = .034) in compression modulus. The shear modulus of the 3D‐printed material was 228.59 (±24.82) KPa while its compression modulus was 668.90 (±13.16) KPa. This material was used to prototype a sophisticated in vitro giant aneurysm rupture model. When subjected to physiological pressures and flow rates, the untreated models consistently ruptured at ~12 min. These results indicate that aneurysm rupture can be recreated consistently in a benchtop in vitro model, utilizing the latest 3D‐printed materials, connected to a physiologically relevant programmable pump. Further studies will investigate the optimization of various aneurysm dome thickness regions within the aneurysm, with tunable rupture times for comparison of aneurysm device deployment and benchtop controls based on the measurable effects of pressure and flow changes within the aneurysm models. These optimized in vitro rupture models could ultimately be used to test the efficacy of device treatment options and rupture risk by quantifying specific device rupture times and aneurysm rupture position.


  • Development of physiologically relevant synthetic thrombus for use in visual analysis of in vitro mechanical thrombectomy device testing

    by Holly Berns, Sophia Robertson, Kailey Lewis, Jesse Wells, Wyatt Clark, Timothy A Becker

    Background Ischemic stroke is a leading cause of death and significant long-term disability worldwide. Mechanical thrombectomy is emerging as a standard treatment for eligible patients. As clinical implementation of stent retrieval and aspiration thrombectomy increases, there is a need for physiologically relevant in vitro device efficacy testing. Critical to this testing is the development of standardized ‘soft’ and ‘hard’ synthetic blood clots that mimic the properties of human thrombi and are compatible with imaging technologies. Synthetic clots allow researchers to extract information regarding clot integration, model hemodynamics, and quantify the physics of thrombectomy. Methods This work develops polyacrylamide and alginate-based synthetic clots that are compatible with particle image velocimetry (PIV) and radiographic imaging techniques while maintaining mechanical properties of ‘soft’ and ‘hard’ human clots. Dynamic mechanical analysis testing using an HR2-Rheometer demonstrates comparable mechanical properties to human clots previously tested by this research group and provided in existing literature. Results The synthetic clots are formulated with either 0.5% w/v polyethylene microspheres for PIV visualization or 20% w/v barium sulfate for angiographic visualization, enabling real-time imaging of clot behavior during thrombectomy simulations. The soft formulation shows compressive and shear properties of ~12 kPa and 2–3 kPa, respectively. The hard clots are 3–4 times stiffer, with compressive and shear properties of 41–42 kPa and 8-9 kPa, respectively. Conclusion Standardized synthetic clots offer a platform for reproducible device testing. This provides a greater understanding of mechanical thrombectomy device efficacy, which may lead to quantifiable advances in device development and eventual improved clinical outcomes.


  • Open Access

    Design, Fabrication, and Characterization of 3D-Printed Multiphase Scaffolds Based on Triply Periodic Minimal Surfaces

    by Josette Vigil, Kailey Lewis, Nicholas Norris, Alp Karakoç, Timothy A. Becker

    The present work investigates the influence of material phases and their volume fractions on the elastic behavior of triply periodic minimal surface (TPMS) scaffolds for the potential modeling of bone scaffolds. A graphical tool using TPMS functions, namely Schwarz-D (diamond), gyroid, and modified gyroid, was developed and used to design and additively manufacture 3D multiphase scaffold models. A PolyJet, UV-cured 3D-printer system was used to fabricate the various TPMS scaffold models using three polymer materials with high, medium, and low stiffness properties. All TPMS models had the same volume fractions of the three polymer materials. Final models were printed into cylinders with a diameter of 20 mm and a height of 8 mm for mechanical testing. The models were subjected to compressive and shear testing using a dynamic mechanical analysis rheometer. All samples were tested at physiologically relevant temperature (37°C) to provide detailed structural characterizations. Microscopic imaging of 3D-printed scaffold longitudinal and cross sections revealed that additive manufacturing adequately recreated the TPMS functions, which created anisotropic materials with variable structures in the longitudinal and transverse directions. Mechanical testing showed that all three TPMS 3D-printed scaffold types exhibited significantly different shear and compressive properties (verifying anisotropic properties) despite being constructed of the same volume fractions of the three UV-printed polymer materials. The gyroid and diamond scaffolds demonstrated complex moduli values that ranged from 1.2 to 1.8 times greater than the modified gyroid scaffolds in both shear and compression. Control scaffolds printed from 100% of each of the three polymers had statistically similar mechanical properties, verifying isotropic properties.


  • Application of nondestructive mechanical characterization testing for creating in vitro vessel models with material properties similar to human neurovasculature

    by Nicholas G. Norris, William C. Merritt, Timothy A. Becker

    Vessel models are a first step in developing endovascular medical devices. However, these models, often made from glass or silicone, do not accurately represent the mechanical properties of human vascular tissue, limiting their use to basic training and proof‐of‐concept testing. This study outlines methods to quantify human vascular tissue mechanical properties and synthetic biomaterials for creating representative vessel models. Human vascular tissue was assessed and compared to silicone and new UV‐cured polymers (VC‐A30) using the following eight mechanical tests: compressive, shear, tensile dynamic elastic modulus, Poisson's ratio, hardness, radial force, compliance, and lubricity. Half of these testing methods were nondestructive, allowing for multiple mechanical and histological characterizations of the same human tissue sample. Histological evaluation of the cellular and extracellular matrix of the human vessels verified that the dynamic moduli and Poison's ratio tests were nondestructive. Fluid absorption by VC‐A30 showed statistically significant softening of mechanical properties, stabilizing after 4 days in phosphate‐buffered saline (PBS). Human vasculature exhibited notably similar results to VC‐A30 in five of eight mechanical tests (≤30% difference) versus two of eight for standard silicone (≤38% difference). Results show that VC‐A30 provides a new option for 3D‐printing translucent in vitro vascular models with anatomically relevant mechanical properties. These new vessel analogs may simulate patient‐specific vessel disease states, improve surgical training models, accelerate new endovascular device developments, and ultimately reduce the need for animal models.


  • Open Access

    Definitions of intracranial aneurysm size and morphology: A call for standardization

    by William C. Merritt, Holly F. Berns, Andrew F. Ducruet, Timothy Andrew Becker

    Background: Intracranial aneurysms (IAs) are classified based on size (maximal dome diameter) as well as additional parameters such as neck diameter and dome-to-neck ratio (DNR). The neurosurgical literature includes a wide variety of definitions for both IA size and neck classifications. Standardizing the definitions of IA size and wide-neck classifications would help eliminate inconsistencies and potential misunderstandings of aneurysm morphology and rupture risk. Methods: We queried the MEDLINE (EBSCO) database using the terms “unruptured IA” and (“small” or “medium” or “large”) and filtered based on publication date, language, and scholarly journals. The resulting articles and their references were further screened for eligibility. This identified 286 records, of which 104 were excluded, leaving 182 articles for analysis. The review found several different IA size classifications and neck classifications. Results: A review of the existing literature describing size and neck classifications revealed 13 size classifications for small aneurysms, four classifications for medium aneurysms, 15 classifications for large aneurysms, and one classification for giant aneurysms. There were also seven different wide-neck classifications found. Conclusion: It is imperative that a standardization in classification be implemented to help interventionalists make the most informed decisions regarding emerging treatment options as new endovascular technologies and devices are emerging with indications based around these classifications. Based on the database findings, this article recommends standardized quantitative measurement ranges for IA size and neck classifications.


  • Open Access

    Application of a rabbit-elastase aneurysm model for preliminary histology assessment of the PPODA-QT liquid embolic

    by April Huckleberry, William Merritt, Trevor Cotter, Christopher Settanni, Mark C. Preul, Andrew F. Ducruet, Timothy Andrew Becker

    Background: PPODA-QT is a novel liquid embolic under development for the treatment of cerebral aneurysms. We sought to test the rabbit-elastase aneurysm model to evaluate the tissue response following PPODA-QT embolization. Methods: Experimental elastase-induced aneurysms were created in fourteen New Zealand White Rabbits. Eight animals were used for aneurysm model and endovascular embolization technique development. Six PPODA-QT-treated animals were enrolled in the study. Control and aneurysm tissues were harvested at acute (n = 2), 1-month (n = 2), and 3-month (n = 2) timepoints and the tissues were prepared for histology assessment. Results: All fourteen rabbit-elastase aneurysms resulted in small and medium aneurysm heights (d: n) ratios. Histological evaluation of four aneurysms, treated with PPODA-QT, demonstrated reorganization of aneurysm wall elastin into a smooth muscle layer, and observed as early as the 1-month survival timepoint. At the aneurysm neck, a homogenous neointimal layer (200–300 μm) formed at the PPODA-QT interface, sealing off the parent vessel from the aneurysm dome. No adverse immune response was evident at 1- and 3-month survival timepoints. Conclusion: PPODA-QT successfully embolized the treated aneurysms. Following PPODA-QT embolization, neointimal tissue growth and remodeling were noted with minimal immunological response. The experimental aneurysms created in rabbits were uniformly small with inconsistent neck morphology. Further testing of PPODA-QT will be conducted in larger aneurysm models for device delivery optimization and aneurysm healing assessment before human clinical investigation.


  • Quantifying the mechanical and histological properties of thrombus analog made from human blood for the creation of synthetic thrombus for thrombectomy device testing

    by William Merritt, Anne Marie Holter, Sharna Beahm, Connor Gonzalez, Timothy A Becker, Aaron Tabor, Andrew F Ducruet, Laura S Bonsmann, Trevor R Cotter, Sergey Frenklakh

    Background Untreated ischemic stroke can lead to severe morbidity and death, and as such, there are numerous endovascular blood-clot removal (thrombectomy) devices approved for human use. Human thrombi types are highly variable and are typically classified in qualitative terms – ‘soft/red,’ ‘hard/white,’ or ‘aged/calcified.’ Quantifying human thrombus properties can accelerate the development of thrombus analogs for the study of thrombectomy outcomes, which are often inconsistent among treated patients. Methods ‘Soft’human thrombi were created from blood samples ex vivo (ie, human blood clotted in sample vials) and tested for mechanical properties using a hybrid rheometer material testing system. Synthetic thrombus materials were also mechanically tested and compared with the ‘soft’ human blood clots. Results Mechanical testing quantified the shear modulus and dynamic (elastic) modulus of volunteer human thrombus samples. This data was used to formulate a synthetic blood clot made from a composite polymer hydrogel of polyacrylamide and alginate (PAAM-Alg). The PAAM-Alg interpenetrating network of covalently and ionically cross-linked polymers had tunable elastic and shear moduli properties and shape memory characteristics. Conclusions Due to its adjustable properties, PAAM-Alg can be modified to mimic various thrombi classifications. Future studies will include obtaining and quantitatively classifying patient thrombectomy samples and altering the PAAM-Alg to mimic the results for use with in vitro thrombectomy studies.